Roselabs Finance Ltd files unaudited Q2 FY2026 results with limited review
The company submitted its unaudited financial statements for the quarter ended 30 June 2026, accompanied by a limited review report, on 17 July 2026.
What Roselabs Finance Ltd announced
Roselabs Finance Ltd (BSE: 531324) filed an unaudited financial results package for the quarter ended 30 June 2026, together with a limited review report prepared by its auditors. The filing was submitted to the Bombay Stock Exchange on 17 July 2026 at 11:12:26 UTC.
The announcement does not provide any quantitative financial data such as revenue, profit before tax, net profit, or balance‑sheet items. It merely confirms that the company has complied with the regulatory requirement to disclose its quarterly performance, albeit on an unaudited basis.
"Unaudited Financial Results along with Limited Review Report for the quarter ended June 30, 2026" – filing title.
Limited review report – what it means
A limited review is a lower‑level assurance engagement compared with a full audit. The auditor performs analytical procedures and inquiries but does not obtain the level of evidence required for an audit opinion. Consequently, the financial statements are not audited and may be subject to adjustments once a full audit is performed for the fiscal year.
The filing indicates that the limited review was completed, but it does not disclose the auditor’s conclusions, any qualifications, or material uncertainties identified during the review.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Roselabs Finance Ltd |
| BSE ticker | 531324 |
| Filing date | 17 July 2026 (11:12:26 UTC) |
| Reporting period | Quarter ended 30 June 2026 |
| Report type | Unaudited financial results + limited review |
| Financial figures disclosed | None in the public filing summary |
| Source | BSE filing (PDF) |
Why this matters for investors
The submission satisfies the statutory requirement for quarterly disclosure, giving investors visibility into the company’s recent operating period. However, because the results are unaudited and no numbers are disclosed, shareholders cannot assess the company’s performance or financial health from this filing alone. The limited review provides a modest level of assurance, but any material misstatements could still be identified in the subsequent full audit for the fiscal year.
Investors should watch for the forthcoming audited annual results, which will contain the detailed financial metrics and auditor’s opinion needed for a thorough evaluation.
Conclusion
Roselabs Finance Ltd has complied with its quarterly reporting obligation by filing unaudited results and a limited review for Q2 FY2026 on 17 July 2026. The filing does not reveal any financial numbers, and the limited review does not constitute an audit opinion. Stakeholders will need to await the audited annual statements to obtain a complete picture of the company’s financial performance.
Frequently asked questions
Related stocks
Source filing: view original